IFP Advisors
KLRA icon

IFP Advisors’s Kailera Therapeutics KLRA Stock Holding History

IFP Advisors’s Portfolio KLRA Stock Details KLRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$548 Buy
+48
New +$811 ﹤0.01% 4656

Other funds holding KLRA

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors's KLRA Position: Q3 2026 in Review

IFP Advisors opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 48 shares worth $548. The stake represents ﹤0.01% of the portfolio and ranks #4656 among its holdings.

7 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • IFP Advisors held 48 shares of Kailera Therapeutics worth $548 as of Q3 2026.
  • Kailera Therapeutics was a new IFP Advisors position in Q3 2026.
  • Kailera Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4656 holding.
  • 7 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.